Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide in advanced soft tissue sarcoma
NCT00717522Phase 2Terminated
- Sponsor
- Celgene Corporation
- Start
- Aug 2008
- Primary completion
- Jan 2009
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of pomalidomide in soft tissue sarcoma (STS), sponsored by Celgene Corporation. Started Aug 2008; status: terminated.
02
Drugs
pomalidomide
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00717522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00717522.